Drug Testing Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Research Scope & Content Outline

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Research Methodology
                    1.3. Research Scope & Assumption
                    1.4. Information Procurement
                         1.4.1. Purchased Database
                         1.4.2. GVR’s Internal Database
                         1.4.3. Secondary Sources & Third-Party Perspectives
                         1.4.4. Primary Research
                    1.5. Information Analysis
                         1.5.1. Data Analysis Models
                    1.6. Market Formulation & Data Visualization
                    1.7. Data Validation & Publishing
Chapter 2. Drug Testing Market Intelligence
                    2.1. Category Definition
                    2.2. Category Intelligence
                         2.2.1. Market Size
                         2.2.2. Trends
                         2.2.3. Drivers
                         2.2.4. Challenges
                         2.2.5. Regional/ End-use Application Insights
                    2.3. Technology
                         2.3.1. Emerging Technology
                         2.3.2. Best Practices in the Industry
                    2.4. Regulatory Landscape
                    2.5. Porter’s Five Forces Analysis
                         2.5.1. Bargaining power of suppliers
                         2.5.2. Bargaining power of buyers
                         2.5.3. Threat of substitutes
                         2.5.4. Threat of new entrants
                         2.5.5. Competitive rivalry
Chapter 3. Drug Testing - Supplier Intelligence
                    3.1. Identification of top 10 suppliers
                         3.1.1. Quest Diagnostics Incorporated
                         3.1.2. Abbott Laboratories
                         3.1.3. QuidelOrtho Corporation
                         3.1.4. Thermo Fisher Scientific Inc.
                         3.1.5. Siemens Healthineers
                         3.1.6. Bio-Rad Laboratories, Inc.
                         3.1.7. Agilent Technologies, Inc.
                         3.1.8. Laboratory Corporation of America (Labcorp)
                         3.1.9. Clinical Reference Laboratory, Inc.
                         3.1.10. Cordant Health Solutions
                    3.2. Drug Testing Supplier Landscape
                    3.3. Drug Testing Supplier Ranking Methodology
                         3.3.1. Supplier Operational Capabilities
                              3.3.1.1. Years in Service
                              3.3.1.2. Geographical Service Provision
                              3.3.1.3. Industries Served
                              3.3.1.4. Employee Strength
                              3.3.1.5. Revenue/Sales Turnover
                              3.3.1.6. Certifications
                         3.3.2. Supplier Functional Capabilities
                              3.3.2.1. Gas Chromatography-Mass Spectrometry
                              3.3.2.2. Liquid Chromatography-Mass Spectrometry
                              3.3.2.3. Enzyme-Linked Immunosorbent Assay
                              3.3.2.4. Expanded Opioid Testing
                              3.3.2.5. Evidential Breath Alcohol Testing
                              3.3.2.6. Hair Testing
                              3.3.2.7. Others
                    3.4. Drug Testing - Supplier Scoring Criteria
                    3.5. Drug Testing - Supplier Positional Matrix (SPM)
                         3.5.1. Rulers
                         3.5.2. Challengers
                         3.5.3. Loungers
                         3.5.4. Niches
                    3.6. Drug Testing - Supplier Market Concentration
                         3.6.1. Industry structure
                    3.7. Recommended Suppliers
                         3.7.1. Supplier 1 with detailed profile
                         3.7.2. Supplier 2 with detailed profile
                         3.7.3. Supplier 3 with detailed profile
Chapter 4. Competitive Landscape
                    4.1. Recent Supplier Developments with Measured Impact
                         4.1.1. Joint Ventures
                         4.1.2. Mergers & Acquisitions
                         4.1.3. Collaborations or Partnerships
                         4.1.4. Other major developments
                    4.2. Supply - Demand Analysis
                         4.2.1. Supply Analysis
                         4.2.2. Demand Analysis
Chapter 5. Drug Testing - Pricing and Cost Intelligence
                    5.1. Cost Structure Overview
                         5.1.1. Raw materials
                         5.1.2. Drug testing kits, equipment, and lab supplies
                         5.1.3. Technology
                         5.1.4. Labor
                         5.1.5. Infrastructure and Insurance
                         5.1.6. Others
                    5.2. Factors influencing the prices of Drug Testing
                         5.2.1. Type of tests
                         5.2.2. Number of substances tested
                         5.2.3. Testing and volume
                         5.2.4. Location of testing facilities
                         5.2.5. Customization of testing panels
                         5.2.6. Type of testing provider (in-house, third party, mobile/onsite)
                    5.3. Drug Testing - Pricing Model Analysis
                         5.3.1. Cost plus pricing or,
                         5.3.2. Volume-based pricing or,
                         5.3.3. Flat rate pricing
                    5.4. Drug Testing Service Prices - Suppliers Quotation
Chapter 6. Sourcing Intelligence
                    6.1. Engagement Model
                         6.1.1. Fully Outsourcing Model or,
                         6.1.2. Partial/Hybrid Outsourcing Model or,
                         6.1.3. In-house Product Development Model or,
                         6.1.4. Shared Service Model
                    6.2. Operating Model
                         6.2.1. Basic Provider or,
                         6.2.2. Approved Provider or,
                         6.2.3. Others
                    6.3. KPI/SLA Elements
                    6.4. Negotiation Strategies
                    6.5. LCC/BCC Sourcing Analysis
                         6.5.1. China
                         6.5.2. U.S.
                         6.5.3. France
                         6.5.4. Canada
                         6.5.5. Germany
                         6.5.6. Insights on Top 2 LCC/BCC Countries